Accueil

Sulfamethazine

Sulfamethazine

Spécifications

57-68-1Numéro CAS
200-346-4Numéro CE
4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamideNom IUPAC
C12H14N4O2SFormule chimique
278.33 g/molMasse molaire
sulfamethazine; Sulfadimidine; 57-68-1; Sulfadimerazine; Sulphamethazine; Sulfamezathine; Sulphadimidine; 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide; Sulfadimethylpyrimidine; Sulfadimezine; Sulfadimethyldiazine; Sulfadimesine; Sulphamezathine; Sulphamidine; Sulfadine; Sulfamethiazine; Sulphamethasine; Azolmetazin; Cremomethazine; Dimezathine; Spanbolet; Sulfadimesin; Sulfadimezin; Sulfadimidin; Sulfodimezine; Sulphodimezine; Superseptil; Neazina; Pirmazin; Vertolan; Diazil; Sulphadimethylpyrimidine; Kelametazine; Sulfadimidina; Sulfadimidinum; Sulfametazyny; Sulfodimesin; Superseptyl; Mermeth; Neasina; Sulfa-Isodimerazine; Dimidin-R; Hava-Span; Sulfadimezinum; Sulfametazina; Sulfamidine; Diazyl; Benzenesulfonamide, 4-amino-N-(4,6-dimethyl-2-pyrimidinyl)-; Sa III; Solfadimidina; 4,6-Dimethyl-2-sulfanilamidopyrimidine; 4-Amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide; 2-Sulfanilamido-4,6-dimethylpyrimidine; N-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide; A-502; Sulfamethin; NCI-C56600; 2-(p-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine; DTXSID6021290; 6-(4'-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin; N(1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide; N(1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide; 4-Amino-N-(2,6-dimethyl-4-pyrimidinyl)benzenesulfonamide; Sulfamethazine (USP); 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzene-1-sulfonamide; Calfspan; BN 2409; N(sup 1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide; (p-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin; NSC 67457; NSC-67457; NSC-683529; N(sup 1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide; Sulfamethazine [USP]; 2-(4-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine; AI3-26817; CHEBI:102265; Sulfanilamide, N(sup1)-(4,6-dimethyl-2-pyrimidinyl)-; 48U51W007F; Sulfanilamide, N1-(4,6-dimethyl-2-pyrimidinyl)-; BN-2409; Sulfanilamide, N(1)-(4,6-dimethyl-2-pyrimidinyl)-; DTXCID201290; 4-Amino-N-(4,6-dimethyl-pyrimidin-2-yl)-benzenesulfonamide; Sulmet Oblets; Sustain III; Sulka-S Bolus; Supra Sulfa III; Sustain III Calf; SulfaTECH SR; Sulfanilamide, N(sup1)-(2,6-dimethyl-4-pyrimidinyl)-; RefChem:6269; Smz-Med 454; Sulmet Solution Injectable; Sulfamezathine ('s-mez'); Sulfamethazine Spanbolet II; J01EB03; Sulfamethazine Sustained Release Calf; Sulmet Drinking Water Solution, 12.5%; Sustain III Bolus, Sustain III Calf Bolus; 200-346-4; Sulfadimetine; Calfspan Tablets; SulfaSURE SR Bolus; 4,6-Dimethylsulfadiazine; Diazil (the sulfanilamide); Primazin; MFCD00006066; Sulmet; Sulfadimidine;Sulfadimerazine; Sulfadimidine (INN); MLS000069711; n(sup1)-(2,6-Dimethylpyrimid-4-yl)sulfanilamide; N(Sup1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide; NSC67457; Sulka S Boluses; N(Sup1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide; NSC683529; NCGC00018243-07; [(4-Aminophenyl)sulfonyl](4,6-dimethylpyrimidin-2-yl)amine; SMR000017409; TRISULFAPYRIMIDINES (SULFAMETHAZINE); Solfadimidina [DCIT]; Sulfametazyny [Polish]; SULFADIMIDINE [INN]; F1443-4796; Sulfadimidinum [INN-Latin]; Sulfadimidina [INN-Spanish]; Sulfametazina [Italian]; HSDB 4157; Sulfadimidine [INN:BAN]; CAS-57-68-1; SMZ; CCRIS 3701; EINECS 200-346-4; BRN 0261304; sulfamethazone; ulfamethazine; Diazilsulfadine; Panazin; Sulfamethazine;; Sulphadimidine;; Sulfadimesine;; Sulfadimezine;; Sulfodimezine;; Superseptil;; Sulfadimerazine;; Sulphamezathine;; Sulka k boluses; S-Dimidine; Dimidim-R; UNII-48U51W007F; (p-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin [German]; 6-(4'-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin [German]; Sulfadimidine CRS; 4-Amino-N-(4,6-dimethyl-2-pyrimidyl)benzenesulfonamide; Sentry aq mardel biospheres maracyn plus; Spectrum_000990; Sulfadimethylpyrimidine;; 4-amino-N-(4; Opera_ID_1374; Prestwick0_000775; Prestwick1_000775; Prestwick2_000775; Prestwick3_000775; Spectrum2_001321; Spectrum3_001700; Spectrum4_000344; Spectrum5_001270; Sulfamethazine (Standard); Sulfamethazine, >=99%; CHEMBL446; Epitope ID:122238; Cambridge id 5251384; NCIOpen2_003489; BIDD:PXR0093; Oprea1_142608; Oprea1_677935; BSPBio_000850; BSPBio_003260; CBDivE_012932; KBioGR_000747; KBioSS_001470; SULFAMETHAZINE [HSDB]; SULFAMETHAZINE [IARC]; 5-25-10-00250 (Beilstein Handbook Reference); MLS000103403; MLS001077331; MLS002454449; DivK1c_000293; SCHEMBL151305; SPECTRUM1500548; SULFADIMIDINE [MART.]; SULFAMETHAZINE [VANDF]; SPBio_001441; SPBio_002789; SULFADIMIDINE [WHO-DD]; SULFADIMIDINE [WHO-IP]; BPBio1_000936; orb1310333; orb3140136; SULFAMETHAZINE [USP-RS]; Sulfanilamide, N(sup 1)-(4,6-dimethyl-2-pyrimidinyl)-; ASWVTGNCAZCNNR-UHFFFAOYSA-; GTPL12642; HMS500O15; HY-B0035R; KBio1_000293; KBio2_001470; KBio2_004038; KBio2_006606; KBio3_002480; MSK4014; NINDS_000293; HMS1921A17; HMS2092I19; HMS3652K03; HMS5081I18; Pharmakon1600-01500548; SMSSF-0041082; SULFADIMIDINE [EP IMPURITY]; SULFAMETHAZINE [GREEN BOOK]; ALBB-033473; HY-B0035; SULFADIMIDINE [EP MONOGRAPH]; SULFAMETHAZINE [ORANGE BOOK]; Tox21_110847; Tox21_202221; Tox21_303006; BBL005404; CCG-39259; EBC-03813; MSK4014-100M; NSC757326; s3133; SBB030487; STK097514; SULFADIMIDINUM [WHO-IP LATIN]; SULFAMETHAZINE [USP MONOGRAPH]; AKOS000119894; MSK4014-1000M; SULFOSE COMPONENT SULFAMETHAZINE; Tox21_110847_1; DB01582; FS29663; MS-1576; NSC-757326; IDI1_000293; TERFONYL COMPONENT SULFAMETHAZINE; LANTRISUL COMPONENT SULFAMETHAZINE; NCGC00018243-01; NCGC00018243-02; NCGC00018243-03; NCGC00018243-04; NCGC00018243-05; NCGC00018243-06; NCGC00018243-08; NCGC00018243-09; NCGC00021490-03; NCGC00021490-04; NCGC00021490-05; NCGC00021490-06; NCGC00256371-01; NCGC00259770-01; SULFALOID COMPONENT SULFAMETHAZINE; WLN: T6N CNJ BMSWR DZ& D1 F1; AC-16126; DA-58170; FS182483; NEOTRIZINE COMPONENT SULFAMETHAZINE; ST011913; Sulfadimidine for peak identification CRS; Sulfanilamide,6-dimethyl-4-pyrimidinyl)-; SY101965; SBI-0051522.P003; SULFAMETHAZINE (TRISULFAPYRIMIDINES); pyrimidine, 4,6-dimethyl-2-sulphanilamido-; Sulfamethazine 100 |Ig/mL in Acetonitrile; N1-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide; NS00000199; NS00114258; SW219689-1; Benzenesulfonamide,6-dimethyl-4-pyrimidinyl)-; EN300-16843; Sulfamethazine 100 microg/mL in Acetonitrile; TRIPLE SULFOID COMPONENT SULFAMETHAZINE; C19530; D02436; F85014; N1-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide; Sulfamethazine 1000 microg/mL in Acetonitrile; Sulfamethazine Solution in Methanol, 100ug/mL; AB00052097_12; AB00052097_13; Sulfamethazine Solution in Methanol, 1000ug/mL; F510096; SR-01000000211; Sulfamethazine, Vetec(TM) reagent grade, >=99%; Sulfamethazine, VETRANAL(TM), analytical standard; Q3976823; SR-01000000211-3; BRD-K11640013-001-02-6; BRD-K11640013-001-14-1; BRD-K11640013-001-15-8; BRD-K11640013-236-03-6; BRD-K11640013-236-10-1; Z56791687; 2-(4-Aminobenzenesulfonylamino)-4,6-dimethylpyrimidine; TRISULFAPYRIMIDINES (SULFAMETHAZINE) [ORANGE BOOK]; Sulfadimidine, European Pharmacopoeia (EP) Reference Standard; (4-AMINO-N-(4,6-DIMETHYL-2-PYRIMIDINYL)BENZENE SULFONAMIDE; benzenesulfonamide, 4-amino-N(S)-(4,6-dimethylpyrimidin-2-yl)-; Sulfamethazine, United States Pharmacopeia (USP) Reference Standard; p-aminophenyl(4,6-dimethyl-2-pyrimidinylamino)(oxo)-lambda-sulfaniumolate; Sulfadimidine for peak identification, European Pharmacopoeia (EP) Reference Standard; InChI=1/C12H14N4O2S/c1-8-7-9(2)15-12(14-8)16-19(17,18)11-5-3-10(13)4-6-11/h3-7H,13H2,1-2H3,(H,14,15,16)Synonymes